Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
The Journal of Infectious Diseases
|
January 6, 2018
Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine
Elizabeth B Brickley, Carolyn B Strauch, Wendy F Wieland-Alter, et al.
Pathogens & Immunity
|
June 27, 2024
Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2
Ruth I Connor, Mrunal Sakharkar, C Garrett Rappazzo, et al.
The Lancet. Microbe
|
May 3, 2025
Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trials
Audrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 4, 2025
Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newborns
Audrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
BMJ Global Health
|
September 24, 2019
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden
Elizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 3, 2021
Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike
Andrew R Crowley, Harini Natarajan, Andrew P Hederman, et al.
Elife
|
March 15, 2022
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
Andrew R Crowley, Harini Natarajan, Andrew P Hederman, et al.
The Journal of Infectious Diseases
|
May 29, 2024
Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United States
Audrey Godin, Ruth I Connor, Hanna N Degefu, et al.
BMC Immunology
|
February 17, 2022
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 17, 2021
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2
Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
The Journal of Infectious Diseases
|
January 6, 2018
Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine
Elizabeth B Brickley, Carolyn B Strauch, Wendy F Wieland-Alter, et al.
Pathogens & Immunity
|
June 27, 2024
Characteristics and Functions of Infection-enhancing Antibodies to the N-terminal Domain of SARS-CoV-2
Ruth I Connor, Mrunal Sakharkar, C Garrett Rappazzo, et al.
The Lancet. Microbe
|
May 3, 2025
Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trials
Audrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 4, 2025
Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newborns
Audrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
BMJ Global Health
|
September 24, 2019
Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden
Elizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 3, 2021
Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike
Andrew R Crowley, Harini Natarajan, Andrew P Hederman, et al.
Elife
|
March 15, 2022
Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
Andrew R Crowley, Harini Natarajan, Andrew P Hederman, et al.
The Journal of Infectious Diseases
|
May 29, 2024
Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United States
Audrey Godin, Ruth I Connor, Hanna N Degefu, et al.
BMC Immunology
|
February 17, 2022
Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 17, 2021
Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2
Harini Natarajan, Shiwei Xu, Andrew R Crowley, et al.
Page
of 5